Sinovac Biotech Ltd (SVA)
6.47
0.00 (0.00%)
USD |
NASDAQ |
Apr 22, 16:00
Sinovac Biotech Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2020 | 33.24% |
| September 30, 2020 | 9.67% |
| June 30, 2020 | -7.19% |
| March 31, 2020 | -38.09% |
| December 31, 2019 | 28.60% |
| September 30, 2019 | 12.11% |
| June 30, 2019 | 18.97% |
| March 31, 2019 | 4.89% |
| December 31, 2018 | -2.19% |
| September 30, 2018 | 16.43% |
| June 30, 2018 | 7.62% |
| March 31, 2018 | 17.66% |
| December 31, 2016 | 14.18% |
| September 30, 2016 | 11.15% |
| June 30, 2016 | -694.2% |
| March 31, 2016 | 11.95% |
| December 31, 2015 | 0.71% |
| September 30, 2015 | -9.53% |
| June 30, 2015 | 12.28% |
| March 31, 2015 | -24.45% |
| December 31, 2014 | 3.18% |
| September 30, 2014 | 0.52% |
| June 30, 2014 | -18.59% |
| March 31, 2014 | 0.03% |
| December 31, 2013 | 26.23% |
| Date | Value |
|---|---|
| September 30, 2013 | 10.46% |
| June 30, 2013 | 7.56% |
| March 31, 2013 | -19.99% |
| December 31, 2012 | -23.52% |
| September 30, 2012 | -21.01% |
| June 30, 2012 | -17.41% |
| March 31, 2012 | -93.97% |
| December 31, 2011 | 13.10% |
| September 30, 2011 | -13.95% |
| June 30, 2011 | 8.45% |
| March 31, 2011 | -60.98% |
| December 31, 2010 | -97.88% |
| September 30, 2010 | -3.12% |
| June 30, 2010 | 10.18% |
| March 31, 2010 | -6.92% |
| December 31, 2009 | 24.46% |
| September 30, 2009 | 24.62% |
| June 30, 2009 | 29.02% |
| March 31, 2009 | 0.38% |
| December 31, 2008 | 19.21% |
| September 30, 2008 | 8.45% |
| June 30, 2008 | 20.19% |
| March 31, 2008 | 17.60% |
| December 31, 2007 | 21.66% |
| September 30, 2007 | 20.23% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-38.09%
Minimum
Mar 2020
33.24%
Maximum
Dec 2020
8.19%
Average
12.11%
Median
Sep 2019
Profit Margin (Quarterly) Benchmarks
| CASI Pharmaceuticals Inc | -88.09% |
| Zai Lab Ltd | -145.0% |
| I-MAB | -- |
| Gracell Biotechnologies Inc (DELISTED) | -- |
| Adagene Inc | -- |